Overview

Anti-Oxidant Treatment of Alzheimer's Disease

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).

Phase:

Phase 1

Details

Lead Sponsor:

National Institute on Aging (NIA)

Collaborator:

Alzheimer's Disease Cooperative Study (ADCS)

Treatments:

alpha-Tocopherol
Antioxidants
Ascorbic Acid
Thioctic Acid
Tocopherols
Tocotrienols
Ubiquinone
Vitamin E
Vitamins